Herpesviruses and the innate immune response

被引:80
作者
Mossman, KL [1 ]
Ashkar, AA [1 ]
机构
[1] McMaster Univ, Dept Pathol & Mol Med, Ctr Gene Therapeut, Hamilton, ON L8N 3Z5, Canada
关键词
D O I
10.1089/vim.2005.18.267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Herpesvirus infection leads to the rapid induction of an innate immune response. A central aspect of this host response is the production and secretion of type I interferon. The current model of virus-mediated interferon production includes three stages: sensitization, induction, and amplification. A key mediator of all three stages is the cellular transcription factor interferon regulatory factor 3 (IRF3). Although the precise details of IRF3 activation and interferon production in response to herpesvirus infection are still being elucidated, viral proteins that block components of the interferon pathway, particularly IRF3, have been identified and characterized. In vivo studies have shown that in addition to type I interferon, interleukin-15 (IL-15) and natural killer (NK) cells also play an important role in mediating resistance to herpesvirus infection. Recent investigations have demonstrated a strong association between IRF3, interferon, IL-15, and NK cells. This review will focus on herpesvirus-mediated induction of innate immunity, the central role of the type I interferon response and mechanisms used by herpesviruses to block host antiviral immunity.
引用
收藏
页码:267 / 281
页数:15
相关论文
共 173 条
[1]   Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response [J].
Abate, DA ;
Watanabe, S ;
Mocarski, ES .
JOURNAL OF VIROLOGY, 2004, 78 (20) :10995-11006
[2]   Inhibition of human herpes simplex virus type 2 by interferon γ and tumor necrosis factor α is mediated by indoleamine 2,3-dioxygenase [J].
Adams, O ;
Besken, K ;
Oberdörfer, C ;
MacKenzie, CR ;
Rüssing, D ;
Däubener, W .
MICROBES AND INFECTION, 2004, 6 (09) :806-812
[3]   Impaired induction of IL-15 in response to herpes simplex virus type 1 infection in peripheral blood mononuclear cells of HIV-infected patients [J].
Ahmad, A ;
Ahmad, R ;
Toma, E ;
Morisset, R ;
Menezes, J .
AIDS, 2000, 14 (06) :744-746
[4]   Innate immune response of the human host to exposure with herpes simplex virus type 1: In vitro control of the virus infection by enhanced natural killer activity via interleukin-15 induction [J].
Ahmad, A ;
Sharif-Askari, E ;
Fawaz, L ;
Menezes, J .
JOURNAL OF VIROLOGY, 2000, 74 (16) :7196-7203
[5]  
Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO
[6]  
2-U
[7]   Activation of IκB kinase by herpes simplex virus type 1 -: A novel target for anti-herpetic therapy [J].
Amici, C ;
Belardo, G ;
Rossi, A ;
Santoro, MG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (31) :28759-28766
[8]   Induction of interferon-α by glycoprotein D of herpes simplex virus:: A possible role of chemokine receptors [J].
Ankel, H ;
Westra, DF ;
Welling-Wester, S ;
Lebon, P .
VIROLOGY, 1998, 251 (02) :317-326
[9]   Toll-like receptor (TLR)-3, but not TLR4, agonist protects against genital herpes infection in the absence of inflammation seen with CpG DNA [J].
Ashkar, AA ;
Yao, XD ;
Gill, N ;
Sajic, D ;
Patrick, AJ ;
Rosenthal, KL ;
Rosenthal, L .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (10) :1841-1849
[10]   Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection [J].
Ashkar, AA ;
Rosenthal, KL .
JOURNAL OF VIROLOGY, 2003, 77 (18) :10168-10171